Rigel Announces Closing of Licensing Agreement for VEPPANU™ (vepdegestrant)
Go back to Rigel Announces Closing of Licensing Agreement for VEPPANU™ (vepdegestrant)| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 37.48 -0.32 (0.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.80 | 52 Week High | $4.38 | |||
| Open | $37.04 | 52 Week Low | $1.88 | |||
| Day High | $38.00 | P/E | N/A | |||
| Day Low | $36.54 | EPS | $-1.12 | |||
| Volume | 231,974 | |||||
